Improving Breast Cancer Outcome Predictions with Gene Expression Data
Author Information
Author(s): Zhang Zhe, Chen Dechang, Fenstermacher David A
Primary Institution: University of North Carolina, Chapel Hill
Hypothesis
Can integrated analysis of multiple gene expression datasets improve the predictability of breast cancer outcomes?
Conclusion
The study confirmed that integrating multiple datasets for gene expression profiles leads to better predictions of breast cancer recurrence.
Supporting Evidence
- The integrated profiling of two independent datasets led to higher classification accuracy (71.11% vs. 70.59%).
- Cell cycle, especially M phase mitosis, was significantly overrepresented by the 60-gene profile obtained from integrated analysis.
- The profiles significantly differentiated poor and good prognosis in a third patient cohort.
Takeaway
Scientists looked at gene data from many breast cancer patients to make better predictions about who might get sick again after treatment.
Methodology
The study used integrated analysis of two independent datasets and validated the results with a third dataset, employing random re-sampling and cross-validation.
Potential Biases
The results may be influenced by the clinical characteristics of the patient samples, such as ER and lymph node status.
Limitations
The study's findings may be confounded by the clinical backgrounds of the patient cohorts used.
Participant Demographics
The study involved breast cancer patients classified into good and poor prognosis groups based on recurrence within three years.
Statistical Information
P-Value
0.003
Confidence Interval
95% CI not specified
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website